SANUWAVE Health, Inc. (SNWV)
NASDAQ: SNWV · Real-Time Price · USD
1.820
+0.240 (15.19%)
Nov 13, 2026, 4:00 PM EST - Market closed
SANUWAVE Health Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 16 | 256 | 196 | 15 | 13 | 82 | |
Market Cap Growth | -94.53% | 30.38% | 1223.81% | 18.51% | -84.72% | -5.27% |
Enterprise Value | 29 | 271 | 228 | 53 | 45 | 101 |
Last Close Price | 1.82 | 29.84 | 23.00 | 4.87 | 8.55 | 63.75 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 10.79 | 21.66 | - | - | - | - |
Forward PE | - | 38.26 | - | - | - | - |
PS Ratio | 0.38 | 5.81 | 6.02 | 0.73 | 0.75 | 6.29 |
PB Ratio | 5.49 | 158.07 | -12.43 | -0.34 | -0.30 | -2.10 |
P/FCF Ratio | 6.02 | 132.32 | 99.89 | - | - | - |
P/OCF Ratio | 4.76 | 66.03 | 79.95 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.70 | 6.15 | 6.98 | 2.62 | 2.70 | 7.73 |
EV/EBITDA Ratio | 15.78 | 36.17 | 36.71 | 109.55 | - | - |
EV/EBIT Ratio | 54.14 | 41.58 | 42.05 | - | - | - |
EV/FCF Ratio | 11.03 | 140.00 | 115.92 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 6.88 | 14.19 | -1.63 | -0.74 | -1.00 | -0.72 |
Debt / EBITDA Ratio | 9.19 | 3.02 | 4.16 | 65.46 | - | - |
Debt / FCF Ratio | 7.54 | 11.88 | 13.13 | - | - | - |
Net Debt / Equity Ratio | 4.58 | 6.80 | -0.98 | -0.70 | -0.97 | -0.71 |
Net Debt / EBITDA Ratio | 7.17 | 1.47 | 2.51 | 61.78 | -4.99 | -2.13 |
Net Debt / FCF Ratio | 5.01 | 5.69 | 7.92 | -6.64 | -2.33 | -3.96 |
Asset Turnover | 1.21 | 1.31 | 1.24 | 0.97 | 0.87 | 0.63 |
Inventory Turnover | 1.45 | 2.00 | 2.28 | 3.16 | 4.54 | 2.50 |
Quick Ratio | 0.70 | 0.97 | 0.30 | 0.08 | 0.09 | 0.05 |
Current Ratio | 1.18 | 1.38 | 0.41 | 0.15 | 0.11 | 0.08 |
Return on Assets (ROA) | 0.97% | 12.07% | 12.89% | -1.60% | -29.07% | -42.45% |
Return on Invested Capital (ROIC) | 3.38% | - | - | - | - | - |
Return on Capital Employed (ROCE) | 3.30% | 33.40% | -35.40% | 1.30% | 22.20% | 37.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 9.27% | 4.62% | -16.86% | -174.05% | -82.27% | -33.29% |
FCF Yield | 16.61% | 0.76% | 1.00% | -30.61% | -137.23% | -8.47% |
Buyback Yield / Dilution | -5.22% | -103.51% | -110.82% | -44.47% | -6.00% | -37.08% |